Wellesley Hills, MA, United States of America

Saurabh Saha

USPTO Granted Patents = 37 (Patent Applications = 14)

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 12 (Patent Applications = 19)

Average Co-Inventor Count = 4.7

ph-index = 4

Forward Citations = 82(Granted Patents)

Location History:

New York, NY (US) (2010)
Leawood, KS (US) (2015 - 2022)
Wellesley Hills, MA (US) (2017 - 2024)

Company Filing History:

33 out of 40

Biomed Valley Discoveries, Inc.

patents

15 out of 3,435

National Institutes of Health, a Component of the US Dept. of Health & Human Services

patents

3 out of 3,682

The Johns Hopkins University

patents

4. 2 out of 21

Synlogic Operating Company, Inc.

The United States of America As Represented by the Department of Health

patents

where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...

37 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12433920 - C. novyi for the treatment of solid tumors in non-human animals (2025-10-07),

2. 12427173 - Use of bacteria, bacterial products, and other immunoregulatory entities in combination with anti-CTLA-4 and/or anti-PD-1 antibodies to treat solid tumor malignancies (2025-09-30),

3. 12076324 - Cancer treatments using combinations of CDK and ERK inhibitors (2024-09-03),

4. 11851498 - Anti-CD276 antibodies (B7H3) (2023-12-26),

5. 11723932 - Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells (2023-08-15),

6. 11679112 - Cancer treatments using combinations of CDK and ERK inhibitors (2023-06-20),

7. 11512138 - Anti-CD276 polypeptides, proteins, and chimeric antigen receptors (2022-11-29),

8. 11471494 - Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells (2022-10-18),

9. 11439669 - C. novyi for the treatment of solid tumors in humans (2022-09-13),

10. 11246859 - Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancers (2022-02-15),

11. 11135225 - Cancer treatments using combinations of CDK and ERK inhibitors (2021-10-05),

12. 11034757 - Combination therapies using agents that target tumor-associated stroma or tumor cells and tumor vasculature (2021-06-15),

13. 11033621 - Combination therapies targeting tumor-associated stroma or tumor cells (2021-06-15),

14. 11033620 - Combination therapies targeting tumor-associated stroma or tumor cells and microtubules (2021-06-15),

15. 11033537 - LPT-723 and immune checkpoint inhibitor combinations and methods of treatment (2021-06-15),

Title: Inventor Saurabh Saha - Revolutionizing Technology

Introduction: Saurabh Saha, a visionary inventor based in Wellesley Hills, MA, is renowned for his groundbreaking contributions to the field of technology. With a passion for innovation and a keen eye for detail, he has made significant strides in various industries.

Latest Patents: Saurabh Saha holds several patents in cutting-edge technologies related to artificial intelligence, renewable energy, and biotechnology. His recent patents focus on enhancing user experience through intuitive interfaces and streamlining complex processes.

Career Highlights: Throughout his illustrious career, Saurabh Saha has worked with top research institutions and leading tech companies to bring his ideas to life. His innovative solutions have garnered widespread acclaim and have been instrumental in shaping the future of technology.

Collaborations: Saurabh Saha has collaborated with a diverse range of experts, including engineers, scientists, and designers, to push the boundaries of innovation. His collaborative approach has led to the development of groundbreaking products that have transformed industries.

Conclusion: In conclusion, Saurabh Saha's relentless pursuit of innovation and his unwavering commitment to excellence have established him as a trailblazer in the world of technology. His passion for creating transformative solutions continues to inspire the next generation of inventors and innovators.

This text is generated by artificial intelligence and may not be accurate.